Role of economic models in randomized clinical trials
Open Access
- 31 May 1999
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 137 (5) , S41-S46
- https://doi.org/10.1016/s0002-8703(99)70427-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multivessel coronary artery diseaseThe American Journal of Cardiology, 1995
- Confidence intervals for cost/effectiveness ratiosHealth Economics, 1995
- Cost Effectiveness of Thrombolytic Therapy with Tissue Plasminogen Activator as Compared with Streptokinase for Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994
- The Journal's Policy on Cost-Effectiveness AnalysesNew England Journal of Medicine, 1994
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsPublished by Elsevier ,1994
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Economic Analysis in Randomized Control TrialsMedical Care, 1992
- Statistical Data Analysis in the Computer AgeScience, 1991